Stock Analysts

Fed Minutes Uncover a Donnybrook (BAC) (JPM)

The minutes to the most recent Federal Reserve Meeting, held on August 8th just came out and show that the Fed is deeply divided on economic policy. Below are the key parts of the participants’ views section of the minutes . I intersperse my commentary/translation from time to time […]

Stock Analysts

Milestone for ZOLL LifeVest (MDT) (PHG) (ZOLL)

Resuscitation devices maker ZOLL Medical ’s ( ZOLL ) flagship LifeVest wearable defibrillator has achieved another key milestone as it has been reportedly prescribed by physicians at all of the 17 “ Honor Roll” hospitals and all of the 50 “Best Cardiology and Heart Surgery” hospitals designated by U.S. News and World Report for 2011-2012. The Massachusetts-based company has achieved this milestone for the fourth consecutive year. […]

Fast Money Episodes

Tablet Wars: AMZN vs. APPLE

[cnbc 3000042833] Discussing whether Amazon can challenge Apple’s tablet domination, with Neil Herman, Ticonderoga Securities analyst. Herman also provides insight on Microsoft, and whether it will raise its dividend. […]

Fast Money Episodes

Recession Dangerously Close?

[cnbc 3000042832] The market has turned around 4% recently, but does that mean we’re in the clear? Mark Zandi, Moody’s Analytics, explains why the US economy is close to another recession. […]

Stock Analysts

FDA Approves J&J Pain Drug (JNJ) (VRTX)

Johnson & Johnson ( JNJ ) recently gained US Food and Drug Administration (FDA) approval for its extended release (ER) version of pain drug, Nucynta. The FDA approved Nucynta ER for the management of moderate to severe chronic pain in adults requiring continuous, round-the-clock opioid analgesic for an extended period of time. Nucynta ER will be available under a Risk Evaluation and Mitigation Strategy (REMS) which will help convey the risks associated with its use. […]

Stock Analysts

Vodafone, Wind Hellas in Talks (T) (VOD) (VZ)

British mobile phone giant Vodafone Group Plc ( VOD ) is in talks to combine its Greece operation with privately owned Wind Hellas Telecommunications SA. Both Vodafone and Wind Hellas, Greece’s second and third largest mobile telecoms operators, respectively, are suffering from difficult market conditions due to the stretched Greek economy, thereby hurting overall revenues. […]

Stock Analysts

Green Mountain Sheds Business (GMCR) (PEET) (SBUX)

Green Mountain Coffee Roasters Inc. ( GMCR ) announced that it is selling its US Van Houtte business to Aramark Refreshment Services LLC for about $145 million. The Van Houtte business, also known as Filterfresh Business, roasts and markets gourmet coffee for home and office consumption. […]

Stock Analysts

Juniper Launches New Cloud Offering (CHL) (CSCO) (HPQ) (JNPR) (T) (VZ)

Networking component major Juniper Network ( JNPR ) is gradually tightening its grip on the cloud computing market. The company recently made significant additions to the Juniper Networks vGW Virtual Gateway solution for customers looking for a comprehensive virtualization security platform. These newly added functions with virtualization-specific antivirus (AV) will secure and continuously monitor malware and hackers, as well as ensure that security does not impede virtualized workload performance or present a barrier to implementing large-scale virtualized environments […]

Stock Analysts

CSC’s Deal Wins Continue (ACN) (CSC) (HPQ)

Technology major Computer Sciences Corporation ( CSC ) has been on a deal winning spree in recent times. Recently, the company won two contracts worth $83.2 billion to provide management, operational and logistical support for its Mail Transport Equipment Service Centers (MTESCs). […]

Stock Analysts

EU Approval for Lilly’s Trajenta (AMLN) (LLY)

Eli Lilly and Company ( LLY ) and Boehringer Ingelheim recently gained European Union approval for their type II diabetes treatment, Trajenta (linagliptin). The European Commission approved Trajenta for use in combination with metformin and metformin plus sulfonylurea. Trajenta can also be used as a monotherapy in patients inadequately controlled by diet and exercise alone and patients who are intolerant to metformin or for whom metformin is contraindicated due to renal impairment […]

Stock Analysts

LaSalle Hotels to Repurchase Shares (HST) (LHO)

LaSalle Hotel Properties ( LHO ), a lodging real estate investment trust (REIT), has recently announced that its Board of Trustees has ratified a share repurchase program to buy back common shares worth $100 million. The strategic move is aimed to capitalize on a relatively undervalued share price that seems to be a fallout of the volatility in the market amid fears of a double-dip recession. During April 2011, when the share price was fairly stable in the range of $25-$28, LaSalle Hotel Properties sold 417,037 common shares through its at-the-market share offering program and an additional 7.9 million shares in an underwritten public offering […]